Distribution of the number of PrEP users and PrEP need in England during the precommissioning (PrEP Impact Trial—October 2017–February 2020) and postcommissioning (2021) period of PrEP by ethnicity and gender
| Ethnicity | Gender | Precommissioning (October 2017–February 2020) | Postcommissioning (2021) | ||||
| PrEP users N (%) | Non-late new HIV dx N (%) | PnR | PrEP users N (%) | Non-late new HIV dx N (%) | PnR | ||
| White | Men | 15 669 (73.6%) | 2196 (43.8%) | 7.1 | 41 765 (69.2%) | 435 (35.3%) | 96.0 |
| Women | 367 (1.7%) | 367 (7.3%) | 1.0 | 714 (1.2%) | 90 (7.3%) | 7.9 | |
| Subtotal | 16 061 (75.4%) | 2564 (51.1%) | 6.3 | 44 106 (73.0%) | 526 (42.6%) | 83.9 | |
| Black African | Men | 339 (1.6%) | 293 (5.8%) | 1.2 | 1050 (1.7%) | 79 (6.4%) | 13.3 |
| Women | 36 (0.2%) | 395 (7.9%) | 0.1 | 42 (0.1%) | 122 (9.9%) | 0.3 | |
| Subtotal | 376 (1.8%) | 688 (13.7%) | 0.5 | 1131 (1.9%) | 201 (16.3%) | 5.6 | |
| Black Caribbean | Men | 341 (1.6%) | 86 (1.7%) | 4.0 | 964 (1.6%) | 28 (2.3%) | 34.4 |
| Women | 9 (0.0%) | 38 (0.8%) | 0.2 | 19 (0.0%) | 15 (1.2%) | 1.3 | |
| Subtotal | 350 (1.6%) | 124 (2.5%) | 2.8 | 996 (1.6%) | 43 (3.5%) | 23.2 | |
| Black Other | Men | 128 (0.6%) | 66 (1.3%) | 1.9 | 336 (0.6%) | 22 (1.8%) | 15.3 |
| Women | 6 (0.0%) | 43 (0.9%) | 0.1 | 13 (0.0%) | 7 (0.6%) | 1.9 | |
| Subtotal | 134 (0.6%) | 109 (2.2%) | 1.2 | 358 (0.6%) | 29 (2.4%) | 12.3 | |
| Asian | Men | 1041 (4.9%) | 240 (4.8%) | 4.3 | 4413 (7.3%) | 69 (5.6%) | 64.0 |
| Women | 46 (0.2%) | 51 (1.0%) | 0.9 | 86 (0.1%) | 13 (1.1%) | 6.6 | |
| Subtotal | 1092 (5.1%) | 292 (5.8%) | 3.7 | 4616 (7.6%) | 82 (6.6%) | 56.3 | |
| Mixed/other | Men | 1646 (7.7%) | 411 (8.2%) | 4.0 | 4675 (7.7%) | 76 (6.2%) | 61.5 |
| Women | 87 (0.4%) | 85 (1.7%) | 1.0 | 175 (0.3%) | 25 (2.0%) | 7.0 | |
| Subtotal | 1740 (8.2%) | 497 (9.9%) | 3.5 | 4960 (8.2%) | 101 (8.2%) | 49.1 | |
| Not stated | Men | 1462 (6.9%) | 505 (10.1%) | 2.9 | 3966 (6.6%) | 186 (15.1%) | 21.3 |
| Women | 72 (0.3%) | 240 (4.8%) | 0.3 | 149 (0.2%) | 66 (5.3%) | 2.3 | |
| Subtotal | 1539 (7.2%) | 745 (14.8%) | 2.1 | 4217 (7.0%) | 252 (20.4%) | 16.7 | |
| Latin American* | Men | 714 (3.4%) | 216 (4.3%) | 3.3 | 2459 (4.1%) | 49 (4.0%) | 50.2 |
| Women | 81 (0.4%) | 21 (0.4%) | 3.9 | 218 (0.4%) | 4 (0.3%) | 54.5 | |
| Subtotal | 796 (3.7%) | 238 (4.7%) | 3.3 | 2702 (4.5%) | 52 (4.2%) | 52.0 | |
*Latin American is not an ethnicity readily available in the GUMCAD STI surveillance system and HARS datasets and was derived from the attendee’s country of birth (Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Argentina, Bolivia, Bouvet, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, South Georgia and the South Sandwich Islands, Suriname, Uruguay, Venezuela)
HARS, HIV and AIDS Reporting System; PnR, PrEP-to-need ratio; PrEP, pre-exposure prophylaxis.